|
| 37503540 | A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant. | | 2023 |
| 35953526 | European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). | Neuro Oncol | 2023 |
| 36336490 | CSF biomarkers in primary CNS lymphoma. | Revue Neurologique | 2023 |
| 36402300 | Molecular and clinical diversity in primary central nervous system lymphoma. | Annals of Oncology | 2023 |
| 36318828 | SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era. | Leukemia and Lymphoma | 2023 |
| 38042665 | Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review. | | 2023 |
| 37338525 | Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers. | | 2023 |
| 37462774 | [18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network. | | 2023 |
| 37142871 | Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis. | | 2023 |
| 37456704 | Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective. | | 2023 |
| 37262394 | Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma. | | 2023 |
| 37322012 | Primary central nervous system lymphoma. | Nat Rev Dis Primers | 2023 |
| 36941788 | Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma. | | 2023 |
| 36991231 | Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study. | | 2023 |
| 35147721 | Hybrid [F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy. | Clinical Neuroradiology | 2022 |
| 36248981 | Central nervous system germ cell tumor, an archetypal AYA tumor and a model for pediatric and neuro-oncology collaboration, review from the EURACAN domain 10 group. | Frontiers in Oncology | 2022 |
| 35772168 | Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study. | Blood advances | 2022 |
| 36367044 | Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies. | Current Opinion in Neurology | 2022 |
| 36358611 | Symptoms of Depression and Anxiety in Adults with High-Grade Glioma: A Literature Review and Findings in a Group of Patients before Chemoradiotherapy and One Year Later. | Cancers | 2022 |
| 35834762 | Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study. | Journal of Clinical Oncology | 2022 |
| 35445956 | Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes. | Journal of Neuro-Oncology | 2022 |
| 36093869 | Prognostic factors in primary central nervous system lymphoma. | Current Opinion in Oncology | 2022 |
| 35760933 | Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis. | Neurological Sciences | 2022 |
| 36083426 | Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion. | J Neurooncol | 2022 |
| 36077613 | Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma. | Cancers | 2022 |
| 35945164 | Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group. | Br J Haematol | 2022 |
| 35808822 | Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma. | Clin Transl Med | 2022 |
| 35731991 | Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. | J Clin Oncol | 2022 |
| 35789106 | Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study. | Hematological Oncology | 2022 |
| 35725885 | Chemotherapy is an efficient treatment in primary CNS MALT lymphoma. | Journal of Neuro-Oncology | 2022 |
| 36456685 | Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 |
| 35063776 | Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. | European Journal of Cancer | 2022 |
| 35149927 | Neurological side effects of radiation therapy. | Neurol Sci | 2022 |
| 34580183 | Rituximab-Lenalidomide-Ibrutinib Combination for Relapsed/Refractory Primary CNS Lymphoma: A Case Series of the LOC Network. | Neurology | 2021 |
| 34292201 | Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up. | Current Opinion in Oncology | 2021 |
| 33478735 | BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system. | Revue Neurologique | 2021 |
| 33783067 | TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. | Oncologist | 2021 |
| 33452932 | Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience. | Journal of Neurology | 2021 |
| 33986314 | Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. | Scientific Reports | 2021 |
| 33934060 | Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER). | European Journal of Cancer | 2021 |
| 33658321 | Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome. | Neurology: Neuroimmunology and NeuroInflammation | 2021 |
| 34088874 | Sustained Tumor Control With MAPK Inhibition in <i>BRAF</i> V600-Mutant Adult Glial and Glioneuronal Tumors. | Neurology | 2021 |
| 34298693 | Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives. | Cancers | 2021 |
| 33864703 | Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study. | Am J Hematol | 2021 |
| 33190919 | Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse. | Revue Neurologique | 2021 |
| 32860544 | One-year survival of patients with high-grade glioma discharged alive from the intensive care unit. | Journal of Neurology | 2021 |
| 33130890 | Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033. | Neuro Oncol | 2021 |
| 33077156 | MRI features of intra-axial histiocytic brain mass lesions. | Clinical Radiology | 2021 |
| 33173941 | IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification. | Neuro-Oncology | 2021 |
| 32789684 | Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias. | Support Care Cancer | 2021 |